| Dolasetron - Wikipedia, the free encyclopedia Dolasetron (trade name Anzemet) is a serotonin 5-HT 3 receptor antagonist used to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the ... Read More |
| DOLASETRON - INJECTION (Anzemet) side effects, medical uses, and ... Consumer information about the medication DOLASETRON - INJECTION (Anzemet), includes side effects, drug interactions, recommended dosages, and storage information. Read More |
| Dolasetron Facts and Comparisons at Drugs.com All about Dolasetron. View complete and up to date Dolasetron information - part of the Drugs.com trusted medication database. Read More |
| dolasetron medical facts from Drugs.com Physician reviewed dolasetron patient information - includes dolasetron description, dosage and directions. Read More |
| Anzemet Tablets (Dolasetron) Drug Information: Description, User ... Learn about the prescription medication Anzemet Tablets (Dolasetron), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Dolasetron - PubMed Health - National Center for Biotechnology ... Dolasetron is used to prevent nausea and vomiting caused by cancer chemotherapy, anesthesia, or surgery in adults and children 2 years of age and older. Read More |
| Dolasetron: MedlinePlus Drug Information - National Library of ... Dolasetron is used to prevent nausea and vomiting caused by cancer chemotherapy, anesthesia, or surgery in adults and children 2 years of age and older. Read More |
| Dolasetron - Drugs Home Page Dolasetron is a drug that is used to prevent nausea and vomiting caused by chemotherapy or surgery. This eMedTV Web page describes how the drug works, offers ... Read More |
| dolasetron - MSN Health - Medications Dolasetron blocks the actions of chemicals in the body that can trigger nausea and vomiting. Dolasetron is used to prevent nausea and vomiting that ma Read More |
| Dolasetron - Drugs Area Warnings/Precautions: Dolasetron should be administered with caution in patients who have or may develop prolongation of cardiac conduction intervals, particularly QT ... Read More |
